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Abstract Structural information on membrane proteins is
sparse, yet they represent an important class of proteins that
is encoded by about 30% of all genes. Progress has primarily
been achieved with bacterial proteins, but e¡orts to solve the
structure of eukaryotic membrane proteins are also increasing.
Most of the structures currently available have been obtained by
exploiting the power of X-ray crystallography. Recent results,
however, have demonstrated the accuracy of electron crystal-
lography and the imaging power of the atomic force microscope.
These instruments allow membrane proteins to be studied while
embedded in the bi-layer, and thus in a functional state. The low
signal-to-noise ratio of cryo-electron microscopy is overcome by
crystallizing membrane proteins in a two-dimensional protein^
lipid membrane, allowing its atomic structure to be determined.
In contrast, the high signal-to-noise ratio of atomic force mi-
croscopy allows individual protein surfaces to be imaged at sub-
nanometer resolution, and their conformational states to be
sampled. This review summarizes the steps in membrane protein
structure determination and illuminates recent progress.
) 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Biological membranes ful¢ll vital functions as interfaces to
the outside world, as interfaces between cells, and as bound-
aries of intracellular compartments. Thus, biological mem-
branes are related to numerous diseases such as hyperin-
sulinemia, nephrogenic diabetes insipidus, congestive heart
failure, liver cirrhosis, cystic ¢brosis, hyper- and hypotension,
lung edema, epilepsy, and cataract. About 30% of the se-
quenced genes code for membrane proteins. However, only
30 unique structures of membrane proteins have been solved
to atomic resolution, compared to 3000 unique crystal struc-
tures of soluble proteins, because it is di⁄cult to produce
three-dimensional (3D) crystals suitable for X-ray analyses
from detergent-solubilized membrane proteins. Among the
67 membrane protein structures deposited in the protein
data base, 52 are of bacterial origin, suggesting that bacterial
membrane proteins are more easily produced, puri¢ed and
crystallized than those from plants or animals. The challenge
now is to solve the structure of membrane proteins from high-
er organisms and to study their function, dynamics and inter-
action with ligands.
Progress in 3D crystallization of membrane proteins is dis-
tinct: the rate of new structures has recently increased [1^8],
and 3D crystals of the ¢rst animal channel protein, bovine
aquaporin-1 (AQP1), have been produced [9] and its structure
has been solved to 2.2 AC resolution [10]. The strength of this
approach is the well-established technology that allows data
to be collected and structures to be solved to high resolution
with enormous e⁄ciency. Nevertheless, this route to establish
the atomic structure of a membrane protein is still risky as a
result of the crystallization bottleneck. Solution nuclear mag-
netic resonance (NMR) is the other well-established method
for determining atomic structures. It does not require 3D
crystals and, additionally, allows the dynamics of a protein
to be measured. Furthermore, progress towards assessing the
structure of large complexes has been reported [11]. Di⁄cul-
ties with the stability of solubilized membrane proteins, how-
ever, can be a problem. A powerful alternative to determine
the structure of a membrane protein is its reconstitution into
two-dimensional (2D) membrane protein crystals in the pres-
ence of lipids [12]. This approach restores the native environ-
ment of membrane proteins as well as their biological activity.
Cryo-electron microscopy (EM) allows the assessment of the
3D membrane protein structure at close to atomic resolution.
The atomic force microscope (AFM) depicts biological mem-
branes in aqueous solutions, and permits the movement of
single polypeptide loops to be monitored [13]. In addition,
this instrument allows the energetics of membrane protein
interactions with their ligands to be assessed [14,15].
Here we review the steps in membrane protein structure
determination. Expression and puri¢cation of membrane pro-
teins must be optimized for all structure determination tech-
niques. While 3D crystallization methods of membrane pro-
teins have been reviewed recently [16], we summarize current
methods of 2D crystallization. The examples that are pre-
sented here document the power of atomic force microscopy
as well as EM. Finally, we concentrate on the recent progress
resulting from the combination of microscopic techniques,
structural bioinformatics, and molecular dynamics simula-
tions to elucidate the structure and function of membrane
proteins.
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2. Protein expression, solubilization and puri¢cation
Membrane proteins can often not be puri¢ed from natural
sources in the amounts required for structural analyses. This
is especially true for proteins that are normally expressed at
very low levels or for proteins of human origin. The use of
e⁄cient heterologous expression systems as a source of abun-
dant protein is therefore essential. Currently, four major ex-
pression systems can be distinguished: those using bacteria,
yeast, insect cells, or mammalian cells for expression. It
should be obvious that any recombinant protein can be best
expressed in the expression system that most closely resembles
the natural environment of the protein. For mammalian pro-
teins, therefore, a mammalian expression system is likely to
give the best results in terms of structure and functionality of
the protein. Indeed, mammalian membrane proteins often re-
quire speci¢c lipid environments, the presence of certain chap-
erones, and speci¢c post-translational modi¢cations. It is well
known that the use of prokaryotic or lower eukaryotic expres-
sion systems for mammalian proteins can lead to misfolding
or loss of functionality of the protein expressed [17]. From a
production point of view, however, higher eukaryotic expres-
sion systems are much more expensive, more complex in their
handling and often yield less protein per liter of cell culture
than their simpler counterparts (see Fig. 1). It makes sense,
therefore, to check expression of a new recombinant protein
in all systems available at least until the stage where function-
ality and yield can be assessed, and only then decide which
system is best suited for large-scale production. For this pur-
pose, a well-designed and £exible cloning procedure, allowing
easy cloning of the cDNA of interest into the various systems,
is a requirement.
Recently, a very e⁄cient system for the expression of pro-
teins in mammalian cells was developed, not requiring the
often di⁄cult and time-consuming process of making stable
cell lines [18]. With this system, cell lines of various eukaryotic
origins can be infected by the Semliki Forest Virus carrying
the gene of interest under the control of its viral promoter.
For safety reasons, the virus has been made replication de¢-
cient by splitting the RNA replication genes and structural
genes into two di¡erent vectors. As a further safety mecha-
nism, the virus has to be activated by chymotrypsin. In this
way, a transient but highly e¡ective protein production can
take place in a cell line of choice.
After protein production, an intensive screening of deter-
gents is used to identify the detergent that (1) solubilizes the
protein e⁄ciently, (2) allows for puri¢cation of the protein
(e.g. via Ni-a⁄nity chromatography), (3) does not disturb
the structure and function of the protein, and (4) allows re-
constitution into 2D crystals (see below). In addition, some
form of prior stripping of the membranes may be required to
remove membrane-associated proteins [19^21], thereby mak-
ing the membranes more accessible to detergents. Once solu-
bilized, the protein can either be puri¢ed via classical chro-
matographic methods or, more conveniently, via a⁄nity
puri¢cation using tags present in the protein (e.g. His-tag,
FLAG-tag, HA-tag, Streptavidin-tag, etc.). The latter method
is quick and often yields highly pure protein in a single puri-
¢cation step, but tags can change the properties of the protein
and should ideally be cleaved o¡ after puri¢cation. Puri¢ed
and solubilized protein can conveniently be studied by EM of
negatively stained samples. The homogeneity of such prepa-
rations is readily checked and the stability of the protein in
the detergent used can thus be evaluated. Long-term stability
may also be checked in this manner.
3. 2D crystallization
Because biomolecules are beam sensitive and produce a low
image contrast, extensive image averaging is required to re-
trieve high-resolution structural information by cryo-EM.
Averaging can most e⁄ciently be carried out when the mole-
cules are packed in a 2D crystal. With membrane proteins 2D
crystallization also o¡ers the advantage of restoring their na-
tive environment: by exploiting their amphiphilic character,
membrane proteins can be packed into a 2D crystal in the
presence of lipids. Such 2D crystals therefore warrant full
activity of the protein and, importantly, also preserve the
native conformation of hydrophilic loops that are typically
required for interaction with ligands. In 3D crystals, these
are often immobilized in crystal contacts. On the other
hand, 3D crystals are larger, often better ordered and house
106^108 times more unit cells than 2D crystals, explaining why
it is easier to obtain high resolution by X-ray crystallography.
After isolation in detergents, solubilized membrane proteins
are reconstituted into a lipid bi-layer at a lipid-to-protein ratio
of close to one (weight-to-weight). The assembly of lipids and
proteins is driven by detergent removal, which is the main
approach used for 2D crystallization (Fig. 2). While this prin-
ciple of 2D crystallization is rather general, the recipe working
Fig. 1. Evaluation of the existing major expression systems.
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Fig. 2. 2D crystallization by the detergent removal principle. A: Starting conditions: detergent-solubilized proteins are mixed with lipid-deter-
gent micelles. B: Detergent removal using (i) Biobeads [23], (ii) dialysis [24], (iii) dilution [22], and (iv) Biobeads combined with a monolayer at
the air^water interface, which binds His-tagged proteins [25]. C: The resulting 2D crystals can exist as a vesicular or a sheet-like assembly, or
they are trapped at the air^water interface.
Fig. 3. Atomic force microscopy of biomolecules imaged in aqueous solution. A: Surface topograph of a densely packed vesicle containing tet-
ramers of the major intrinsic protein from lens ¢ber cells [29]. B: Topograph of a 2D crystal of AqpZ from Escherichia coli [13]. Single tet-
ramers exposing the periplasmic side are marked by broken circles. C: Topographs of the surface layer of Corynebacterium glutamicum before
(left panel) and after (right panel) removal of two protomers [32]. The bottom panel displays the force^distance curve of the induced unfolding
giving rise to the surface change (broken circles) observed on the panels above. D: Same as for C, except that here all six protomers were re-
moved. The triangles and the arrows in panels C and D mark defects in the layer that facilitate orientation.
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for one membrane protein can rarely be applied to another.
Puri¢cation procedure, pH, ionic strength, detergents and the
speci¢c, protein-bound lipids signi¢cantly a¡ect protein stabil-
ity. For 2D crystallization, the protein concentration, choice
of lipids and detergent as well as the reconstitution kinetics all
are crucial factors whose in£uence is not well predictable [22^
24]. Therefore, these factors must be screened to determine
which conditions are suitable for the protein and will most
likely result in 2D crystals. Results are continuously checked
by EM of negatively stained samples.
Four main techniques are used for 2D crystallization (Fig.
2): (i) the Biobead method (detergent but not lipid is trapped
in nanoscale cavities of polystyrene beads [23]) ; (ii) the dial-
ysis method [24] ; (iii) the dilution method (the lipid^deter-
gent^protein mixture is diluted to bring the detergent below
the critical-micellar concentration (CMC) [22]); and (iv) the
monolayer method (the ternary complex is bound to a func-
tionalized lipid monolayer at the air^water interface and Bio-
beads remove the detergent [25]). Each technique has its own
advantages: the use of Biobeads permits fast and complete
removal of low- as well as high-CMC detergents. Dialysis is
the most successful crystallization method and has produced
the best 2D crystals, although it works e⁄ciently only with
high-CMC detergents. The main advantage of dilution is to
have a complete control of reconstitution kinetics. Thus, the
process can be slowed down when a favorable equilibrium
between proteins, detergents and lipids for 2D crystallization
is reached. Because the ¢nal protein concentration is an issue
in crystallization in general, dilution has its limitation. A nick-
el-chelating lipid monolayer forces His-tagged membrane pro-
teins to be in close contact and to form a monolayer as well,
facilitating the 2D crystallization of unidirectionally oriented
proteins. This concentrating e¡ect permits the design of re-
constitution experiment with small amounts of proteins.
4. Atomic force microscopy
The atomic force microscope (AFM) [26] measures the sur-
face topography by raster scanning the sample laterally below
a sharp stylus that is attached to a £exible cantilever. A servo
system controls the scanner, displacing the sample also verti-
cally to keep the cantilever de£ection constant. An optical
detector resolves de£ections of 0.1 nm, which corresponds to
a force di¡erence of typically 10^50 pN. Thus state-of-the-art
instruments can contour sample topographies in aqueous so-
lutions at forces in this range. By electrostatically balancing
the forces between tip and sample, topographs are recorded
without sample deformation, yielding a lateral resolution that
is usually better than 1 nm and a vertical resolution of typi-
cally 0.1 nm [27]. In combination with high-resolution imag-
ing, the AFM o¡ers the unique possibility of manipulating
biologically active macromolecules under physiological condi-
tions [28]. A further feature of the AFM is the outstanding
signal-to-noise ratio provided in the topographs. As illustrated
by Fig. 3A, single membrane protein complexes (left half) and
densely packed, non-crystalline arrays thereof (right half) can
be imaged at sub-nanometer resolution [29]. Such imaging
capacity makes the AFM the instrument of choice to assess
the structure and oligomeric state of single membrane proteins
within native membranes [30]. This imaging capacity can also
be exploited to observe single biomolecules at work [31] and
to sample the conformational space and energy landscape of a
membrane protein surface [13]. Fig. 3B shows the AFM to-
pography of a 2D crystal of aquaporin-Z (AqpZ). The con-
formational variability on the periplasmic surface of single
AqpZ tetramers (broken circles) can clearly be seen. The sen-
sitivity of the cantilever de£ection detector has made single
molecule force measurements with the AFM possible [14,15].
Force^distance curves are recorded by vertically displacing the
tip towards the sample until a single molecule is attached by
contact-adhesion. Forces developing during subsequent tip-re-
traction re£ect the induced unfolding pathway of the protein.
Acquisition of high-resolution images before and after ‘unzip-
ping’ a biomolecule allows the damage produced to be directly
visualized (Fig. 3C and D) [32,33].
5. Electron microscopy
Transmission EM has progressed steadily, and modern in-
struments equipped with a ¢eld-emission gun (FEG) are now
available that e⁄ciently transfer the atomic scale structural
information from the sample to the image, which represents
a projection of the 3D potential distribution of the object.
Meaningful information, however, can only be extracted
when the sample is structurally preserved in spite of the vac-
uum within the electron optical system. Suitable methods pro-
duce biomolecules embedded in a thin vitri¢ed water layer
[34,35], or embedded in a layer of partially dried and frozen
sugar solution [36]. A combination of staining the sample with
a heavy metal salt to enhance the contrast, and freezing the
sample to preserve the high-resolution structure is found in
the cryo-negative stain sample preparation method [37]. Since
all these samples are highly sensitive to the electron beam,
images are recorded at low electron doses. High-resolution
data of proteins are recorded at doses below 5 electrons/AC 2,
with the sample kept at liquid nitrogen temperature (77 K)
[38], or at doses below 20 electrons/AC 2, when the sample is
kept at liquid helium temperature (4.3 K) [39]. Such recording
doses produce inherently noisy images, whose information
must be extracted by image averaging.
Since images (rather than di¡raction patterns) are recorded,
thousands of single particle projections can be acquired, clas-
si¢ed, aligned, and averaged [40,41]. In this way the complete
information for a full 3D reconstruction of the potential map
is collected without producing any crystals of the particles.
Single particle reconstruction has mainly been used for large
soluble complexes such as the ribosome [42,43], but also for
some solubilized membrane proteins [44]. Due to the limited
size of the individual particles, precise alignment of the pro-
jections requires that the highest possible resolution and con-
trast are available. Therefore, the use of a highly coherent
electron beam produced by a FEG is mandatory [39,41].
The achievable resolution of single particle structure determi-
nation is now getting better than 10 AC .
Images of 2D crystals of membrane proteins, however, al-
low the image signal to be extracted by crystallographic meth-
ods. Using this approach, the atomic structure of bacteriorho-
dopsin (bR) was ¢rst determined [45], and subsequently
re¢ned [46^48] using prototype FEG microscopes while keep-
ing the sample at a few Kelvin. Two other atomic structures
of membrane proteins were subsequently solved using similar
instruments: the light-harvesting complex of plants [49] and
human aquaporin-1 (AQP1) [50]. Recent progress in 2D crys-
tallization has delivered crystals of several transporters (NhaA
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[51], OxlT [52], and SecYEG [53]), of the bacterial rotor of
ATPase [54,55], and of a ClC-type chloride channel [56],
which allowed structure determination to a su⁄cient resolu-
tion (approximately 6 AC ) for visualizing the secondary struc-
ture.
Interpreting a cryo-EM potential map in terms of atomic
protein structure typically still is a challenging task, even
when relatively high-resolution data of better than 4 AC are
available. The ¢rst step is to determine the macromolecular
fold and to trace the backbone through the map. In the case
of membrane proteins, this can be a non-trivial task: although
secondary structure elements like helices and strands may be
clearly distinguishable, the map is frequently poorly de¢ned in
the loop regions. Nevertheless, a number of approaches have
been applied to tackle this problem. First, the backbone trace
(and thereby the 3D fold) can be derived by visual inspection.
In such cases, the presence of a limited number of bulky
groups at particular sites is a prerequisite for the successful
identi¢cation of their location in the experimental map. This
approach was used for bR, the ¢rst membrane protein struc-
ture to be solved by EM [45,46]. Further, structural clues can
be obtained from bioinformatics methods. Extensive sequence
alignments and the analysis of correlated mutations led to
valuable insights in the case of AQP1 [57]. Finally, in the
case of K-helical proteins, automated procedures have been
developed to determine both the location and direction of
individual helices in the map [58,59]. When used in conjunc-
tion with constraints from the sequence (e.g. the maximal
length of a loop), macromolecular folds can be unambigu-
ously derived this way.
Once the fold has been determined, an initial model of the
backbone structure can readily be generated. Depending on
the resolution, what follows are many rounds of manual mod-
el (re)building and re¢nement. The structures of bR [45^48]
and AQP1 [50,60,61] (Fig. 4) have been solved by EM in
this way and were later con¢rmed by X-ray crystallography
[7,10]. These successes demonstrate that even at a resolution
of around 3.5 AC , a cryo-EM map contains su⁄cient structural
information to uniquely de¢ne the atomic structure. The prac-
tical challenge is to ¢nd this optimal structure in the high-
dimensional search space. Since an exhaustive search is not
feasible, there is no straightforward general method to arrive
at the correct (or best possible) solution at this level of reso-
lution. The available tools are for a substantial part the same
as used in X-ray crystallography but, if used inappropriately,
the usually lower resolution may lead to inaccurate interpre-
Fig. 4. Progress in the elucidation of human AQP1. A: At 6 AC resolution the secondary structure becomes visible [71]. B: At 4.5 AC resolution
the details su⁄ce to place the peptide backbone [72], side chains usually not being discernible in the map. C: At 3.8 AC resolution side chains
become distinct. An atomic model can be built by hand [50] and re¢ned using structural bioinformatics [60]. D: The re¢ned structure (in gray)
is compared with the 2.2 AC structure (in yellow) obtained by X-ray crystallography [10]. The ¢gure was generated with DINO (www.dino3d.
org).
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tations of the data, slow convergence of the re¢nement, or
poor model quality. In contrast to X-ray crystallography, ex-
perimental phase information is available in the case of EM.
Unfortunately, this advantage is not as of yet fully exploited.
Currently, only a trained eye can incorporate all the available
structural information into a model. Inevitably however, all
manual intervention potentially leads to model bias. There-
fore, the development of novel automated techniques speci¢-
cally targeted at model building and re¢nement based on EM
data is mandatory.
6. Function
While crystallographic methods provide atomic resolution,
they reveal only the static part of a structure. Although dis-
tinct conformations can sometimes be trapped and resolved
with these techniques, biomolecules in Brownian motion typ-
ically adopt many other conformations that remain invisible.
NMR spectroscopy and AFM can provide insight into such
processes. While the NMR method gives atomic scale infor-
mation of entire ensembles, the AFM allows single molecules
to be monitored over time, albeit at a lower resolution. Single
molecule dynamics, however, can be simulated computation-
ally, allowing the dynamics of biomolecular processes to be
monitored atom by atom at ultra-high time resolution. Cur-
rent molecular dynamics simulations can be carried out on
systems of more than 105 atoms over tens of nanoseconds,
giving a detailed insight into the function of proteins.
A recent example is the simulation of water £ow through
speci¢c membrane pores. To ¢lter 180 liters of blood per day
in the kidneys, water must permeate through human AQP1 at
a rate of 3 billion water molecules per second [62,63]. Such
amazing rates are typical for all aquaporins and raise the
question as to how these highly speci¢c channels allow water
to pass unhindered but prevent the £ow of protons. Molecular
dynamics simulations of systems comprising either an AQP1
tetramer or a glycerol permeation facilitator (GlpF) tetramer,
which are embedded in a lipid bi-layer and surrounded by
water molecules, provided a detailed time-resolved picture of
the water permeation and ion-blockage mechanisms [64,65]
(Fig. 5). The simulations showed spontaneous, bi-directional,
full water permeation events (Fig. 5, right), with rates in close
agreement to the experimentally determined rates [64]. For the
related glycerol facilitator GlpF, spontaneous partial glycerol
permeation events, involving all three glycerol molecules per
channel as observed by X-ray crystallography [3], were also
observed in simulations [66]. Subsequent steered molecular
dynamics simulations allowed the computation of a free en-
ergy pro¢le for glycerol motion along the channel [67].
In the simulations of both aquaglyceroporins, water mole-
cules were found to be strongly oriented in the channel inte-
rior, through a ¢ne-tuned alignment of their dipoles with the
electric ¢eld exerted by the protein, causing water molecules
to rotate by 180‡ upon passage [60,65] (Fig. 5, right). Simu-
lations of the glycerol-free GlpF structure showed that the
electrostatic interactions between water on the one hand,
and the NPA motifs and the dipoles of helices HB and HE
on the other hand, are the main cause for the observed water
rotation [65]. Hydrogen bond competition between water mol-
ecules and the few polar groups in the pore was found to
dominate the energetics of the permeation process [60]. Two
major interaction sites for water molecules were identi¢ed in-
side the channel, the NPA and the aromatic/arginine constric-
tion regions, which were found to weaken the hydrogen bond
interactions along the water ¢le in the channel. As contiguous
hydrogen bonded water chains are known to be e⁄cient pro-
ton conductors, it was suggested that these regions are the
main proton ¢lters [60,65]. From inspection of the charges
Fig. 5. Multi-nanosecond molecular dynamics simulation of water permeation through AQP1 [64]. Left: The simulation system of the AQP1
tetramer (blue) embedded in a lipid bi-layer (yellow/green) surrounded by water (red/white) consisted of approximately 100 000 atoms. Right:
Pathway of a water molecule for one of the spontaneous permeation events observed in the simulations. All water molecules were found to be
strongly oriented in the channel interior, with their dipoles rotating by about 180‡ during permeation.
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along the channel, electrostatic barriers likely also contribute
signi¢cantly to the proton ¢lter, which needs to be studied in
more detail [68].
7. Conclusions and perspectives
Within a decade, membrane protein structure analyses have
progressed tremendously. A growing number of membrane
proteins have been solved to atomic resolution mainly by
X-ray crystallography, which is now being successfully used
by many laboratories. In addition, signi¢cant and steady
progress has been made in atomic force microscopy and elec-
tron crystallography, although these techniques are being de-
veloped by only a small number of groups. These microscopic
techniques cannot compete with X-ray or NMR techniques in
terms of resolution. They do, however, deliver information
that can be combined with structural bioinformatics and mo-
lecular dynamics simulations to establish a detailed under-
standing of membrane protein structure and function.
The ¢rst generation of commercial AFMs has produced a
number of spectacular results that indicate the breadth of
future applications. These will include high-resolution imaging
of native biological membranes, the determination of mem-
brane protein topology by single molecule force measure-
ments, and the direct, time-resolved monitoring of function-
related conformational changes. Such measurements will be
enhanced by the next generation of scanning probe micro-
scopes that is currently being developed by physicists [69].
High-resolution transmission electron microscopes exploit-
ing highly coherent electron beams are now available that
maintain low sample temperatures, warrant negligible drift,
and that transfer the structural information to 2 AC resolution.
In spite of low sample temperatures that reduce beam dam-
age, the fundamental bottle neck to overcome remains the
beam sensitivity of biological matter. Single particle methods
circumvent di⁄culties related to the crystallization of mem-
brane proteins. However, to achieve close to atomic resolution
by this approach is a truly ambitious endeavor [41]. In con-
trast, 2D crystals have been successfully used to reach atomic
resolution. This approach is of particular interest for mem-
brane proteins, because the native environment can be re-
stored, as 2D crystals are reconstituted in the presence of
lipids. As demonstrated with AQP1, 2D crystals can be uti-
lized to assess the function of a membrane channel quantita-
tively, since the number of participating molecules is precisely
known [70]. The ¢rst atomic model of AQP1 has been estab-
lished by electron crystallography [50]. Re¢nement of this
structure using structural bioinformatics has led to an atomic
model [60], which allowed application of molecular dynamics
simulations to study the mechanism of water transport [64].
With the high-resolution structure of AQP1 determined by
X-ray analyses now available [10], the quality of the lower
resolution structure from electron crystallography has been
assessed and found to agree, even in signi¢cant details [68].
This recent comparison stimulates further e¡orts on electron
crystallography, with the goal of improving both data pro-
cessing technology as well as 2D crystallogenesis.
Improving instrumentation, sample preparation methods,
and data retrieval and processing are di⁄cult tasks, but prog-
ress is predictable and steady. In contrast, crystallization of
membrane proteins remains an empirical discipline that is full
of unexpected adversities. The stability and purity of protein
preparations depend on many elusive factors that are closely
related to expression and puri¢cation methods. Therefore, the
ultimate bottleneck of atomic scale structural and functional
analyses of membrane proteins will be their recombinant ex-
pression and subsequent crystallization.
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